Can Chemo Cause Leg Pain? Why It Happens and How to Cope

Chemotherapy causes leg pain in a large share of patients, and it does so through several distinct pathways. The most common culprit is peripheral neuropathy, where chemo drugs damage the nerves serving the feet, calves, and thighs. But nerve damage is only part of the story. Some regimens trigger an acute pain syndrome in muscles and joints that flares days after each infusion, while others raise the risk of blood clots in the legs or even bone damage. Understanding which mechanism is behind your leg pain matters because the coping strategies differ for each one.

Peripheral Neuropathy Is the Most Common Cause

When people talk about chemo-related leg pain, they are usually describing chemotherapy-induced peripheral neuropathy, or CIPN. The drugs most likely to cause it fall into a handful of categories: platinum-based agents like cisplatin and oxaliplatin, taxanes such as paclitaxel and docetaxel, vinca alkaloids like vincristine, proteasome inhibitors such as bortezomib, and immunomodulatory drugs like thalidomide. Platinum-based agents and taxanes tend to be the most damaging to nerves.¹ The severity is closely tied to cumulative dose, meaning the more chemo you receive over time, the worse the neuropathy tends to get.²

In the legs, CIPN typically starts in the toes and feet and works its way upward. The pain varies widely from person to person. Some people describe burning or electric-shock sensations, others feel a deep aching, and many report numbness or tingling that makes it hard to tell where their feet are in space. This last symptom, impaired position sense, is what makes CIPN particularly dangerous because it affects balance and walking even when the pain itself is manageable.

Taxane Acute Pain Syndrome

Separate from neuropathy, taxane drugs (paclitaxel and docetaxel) can trigger an acute pain syndrome that hits the legs hard. In a prospective study of docetaxel patients, roughly three-quarters experienced joint pain and about the same proportion experienced muscle pain at some point during treatment. The pain peaked around days four to five after each infusion, with a median severity of about 4 out of 10, and typically lasted around four days before easing.³ With paclitaxel, symptoms tend to peak around day three after infusion.⁴

What makes this syndrome confusing is that the pain feels like it is coming from joints and muscles, but research suggests it may not actually originate there. When patients were asked to localize the pain, most could not pin it to joints or muscles specifically, and no structural damage to those tissues has been demonstrated. Researchers believe the syndrome results from the chemo drug sensitizing pain receptors and nerve fibers rather than inflaming the joints or muscles themselves.⁵ This distinction matters practically because anti-inflammatory drugs may not help as much as you would expect for what feels like joint pain.

Oxaliplatin and Cold-Triggered Leg Symptoms

Oxaliplatin, a platinum drug used heavily in colorectal cancer regimens, produces a neuropathy pattern unlike any other chemo agent. Almost nine out of ten patients experience acute nerve symptoms with their very first cycle, including sensitivity to cold items, throat discomfort, and muscle cramps.⁶ In the legs, this often manifests as cramping, tingling, or pain triggered by touching anything cold, from a cold floor to a refrigerator handle. Other reported symptoms include leg cramps and abnormal sensations that come and go unpredictably.⁷

This acute cold sensitivity usually starts within hours of the infusion and can last a week or more, fading before the next cycle. With repeated cycles, though, a chronic neuropathy can build on top of the acute episodes, producing lasting numbness and tingling in the feet and lower legs. Patients on oxaliplatin are typically advised to avoid cold drinks, cold air on exposed skin, and reaching into the freezer without gloves during the days after each treatment.

Blood Clots in the Legs

Leg pain during chemo is not always nerve-related. Chemotherapy raises the risk of deep vein thrombosis (DVT), a blood clot that usually forms in the deep veins of the calf or thigh. Chemo drugs can damage the lining of blood vessels and interfere with the body’s natural anticlotting defenses, making clots more likely to form.⁸ In one study of cancer patients on chemotherapy, about half of incidental blood clots showed up in the first three to six months of treatment, and platinum-based regimens increased the risk up to three-fold.⁹

DVT pain differs from neuropathic pain. It tends to be a deep, constant ache or heaviness concentrated in one leg, often accompanied by swelling, warmth, or redness. If you develop sudden one-sided leg swelling or persistent pain in one calf during chemo, that warrants urgent medical attention. A clot left untreated can break loose and travel to the lungs, causing a pulmonary embolism.

Bone Pain From Growth Factor Injections

Many chemo patients receive injections of granulocyte colony-stimulating factor (G-CSF) drugs like filgrastim or pegfilgrastim to boost white blood cell counts and prevent infections. These injections stimulate the bone marrow to ramp up cell production, and the result is bone pain, often felt in the legs, pelvis, and lower back. The mechanism is not fully understood, but histamine release appears to play a role in the inflammatory process that causes the discomfort.¹⁰ Interestingly, there is clinical interest in using antihistamines like loratadine to manage this type of bone pain, and some oncologists already recommend trying it. The pain usually starts a day or two after the injection and resolves within a few days, but for some patients it can be severe enough to need stronger pain relief.

Steroid-Related Bone Damage

Corticosteroids like prednisone and dexamethasone are given alongside many chemo regimens to manage nausea, inflammation, or as part of the cancer treatment itself. A less well-known risk is avascular necrosis, where reduced blood supply causes bone tissue to die. The hip is the most commonly affected joint, and it can produce deep groin, thigh, or leg pain that worsens with weight-bearing.¹¹ In one early report, four lymphoma patients treated with combination chemo that included high-dose prednisone developed hip bone death anywhere from 20 to 42 months after starting therapy, even though some had only received steroids for four to six weeks.¹²

Avascular necrosis is a low-frequency complication, but it is worth knowing about because the pain develops gradually and can be mistaken for arthritis or a chemo side effect that will pass on its own. If hip or groin pain persists or worsens over weeks to months, imaging can catch the problem early enough for treatment to preserve the joint.

Rare Muscle Inflammation

Some chemo drugs can cause actual muscle damage, though this is uncommon. In one documented case, a patient on gemcitabine developed weakness and pain in the thigh muscles. Imaging showed swelling in both quadriceps, and a biopsy revealed muscle tissue that had been damaged and was regenerating. The symptoms resolved completely after gemcitabine was stopped, with no additional treatment needed.¹³ This kind of true drug-induced muscle injury is much rarer than the nerve-related pain that merely feels like it is coming from the muscles, but it underscores the importance of reporting worsening weakness or persistent muscle pain to your oncology team.

Medications That Help

The evidence base for treating chemo-related leg pain pharmacologically is thinner than you might hope, but two drugs have the most support. Duloxetine, an antidepressant that also dampens nerve pain signals, is the only medication with strong randomized trial evidence for painful CIPN. In a placebo-controlled trial, patients on duloxetine reported an average pain decrease roughly three times greater than those on placebo, and about 59% of duloxetine patients reported at least some pain reduction compared with 38% on placebo.¹⁴

Gabapentin is the drug most commonly recommended in practice, with about 80% of oncology nurses and 69% of prescribing providers suggesting it as a first-line option for painful neuropathy. However, clinicians frequently report that drowsiness and fatigue complicate its use, which is a meaningful trade-off for patients already dealing with chemo-related exhaustion.¹⁵ Other options your oncology team may consider include topical pain relievers, low-dose tricyclic antidepressants, or adjustments to the chemo regimen itself. When neuropathy becomes severe enough, oncologists sometimes reduce doses or switch drugs, a decision that involves weighing pain relief against cancer treatment effectiveness.²

Exercise and Physical Therapy

Exercise is one of the more consistently helpful strategies for chemo-related leg pain and the mobility problems it creates. A meta-analysis of randomized controlled trials found that exercise improved CIPN symptom scores, reduced pain, and enhanced both balance and quality of life.¹⁶ The benefits are not limited to cardio or any one exercise type. Strength and endurance training improved lower-limb strength, balance, and function, while closed-chain leg exercises (think squats, leg presses, and step-ups) decreased both tingling and pain.¹⁷

A separate trial found that patients receiving neurotoxic chemo who performed therapeutic exercises had better balance scores, improved quality of life across physical and emotional domains, and lower pain scores compared to a control group.¹⁸ If you are dealing with chemo-related leg pain and have not been referred to a physical therapist or cancer rehabilitation specialist, it is worth asking your oncology team. Even gentle, supervised exercise during treatment can help preserve leg function and reduce symptoms.

Cooling and Compression During Infusions

A growing body of research is looking at whether cooling or compressing the hands and feet during chemo infusions can prevent neuropathy from developing in the first place. The idea is straightforward: cold narrows blood vessels in the extremities, reducing how much toxic drug reaches the peripheral nerves. Several studies have shown that regional limb cooling can lower both the incidence and severity of CIPN, with some finding significantly less neuropathy in patients using cryotherapy during paclitaxel treatment.¹⁹

The evidence is promising but not uniform. A systematic review found that cold therapy was effective in six studies but showed no significant benefit in three others, with differences in cooling methods and temperatures likely explaining some of the inconsistency.²⁰ One randomized trial comparing cryotherapy, compression therapy, and placebo in breast cancer patients on taxanes found that compression therapy (tight-fitting gloves and stockings) actually outperformed cryotherapy. Compression was successful in preventing significant neuropathy at 12 weeks in about 65% of patients versus roughly 41% for both cryotherapy and placebo. Adherence was also much higher with compression because patients found it more tolerable than keeping their hands and feet packed in ice for hours.²¹ Combining the two approaches, known as cryocompression, may offer additional benefit, though the research is still early.

Falls and Mobility Challenges

Leg pain from chemo is not just a comfort issue. Neuropathy in the feet and lower legs erodes balance and changes how people walk. Cancer survivors with persistent CIPN symptoms take more steps but shorter, slower ones, and they report about 1.8 times the fall risk compared to survivors without neuropathy. Increasing symptom severity was linearly tied to worsening function and higher fall risk.²² In another study, patients who had fallen during chemo had more neuropathic symptoms, worse muscle weakness, and more severe balance loss than those who had not. Patients on taxanes were more likely to have fallen than those on platinum-based drugs, and the severity of balance loss and the number of treatment cycles were the strongest independent predictors of falling.²³

Fall rates among cancer survivors have been shown to be roughly double those of people without a cancer history.²⁴ For someone already dealing with fatigue, reduced appetite, and the general toll of treatment, a broken hip or wrist from a fall can be devastating. Practical precautions include removing loose rugs at home, using night lights, wearing well-fitted shoes with non-slip soles, and installing grab bars in the bathroom. If you notice your balance getting worse, raising this with your care team early can get you into physical therapy before a fall happens.

When Leg Pain Lasts After Treatment Ends

One of the most frustrating aspects of chemo-related leg pain is that it does not always go away when treatment stops. In a study of cancer survivors with persistent neuropathy, the average duration of symptoms was close to four years in the lower extremities.²⁵ Some patients recover fully within months, but others are left with long-term numbness, tingling, or pain that becomes part of their daily life well into survivorship. The reasons for this variability are not entirely clear, though cumulative dose, drug type, and individual biology all play roles.

Genetic factors are an active area of research. A study of gynecologic cancer survivors found that combining genetic markers with clinical characteristics improved the ability to predict who would develop worse neuropathy symptoms compared to using clinical factors alone.²⁶ In the future, pharmacogenomic testing might help oncologists identify patients at highest risk before treatment begins and tailor regimens accordingly. For now, though, being proactive about reporting symptoms early remains the most practical approach, as catching worsening neuropathy in time to adjust doses can mean the difference between temporary pain and permanent nerve damage.

Tracking and Communicating Your Symptoms

One challenge with chemo-related leg pain is that oncologists and patients often perceive the severity differently. Clinician-based grading scales tend to underestimate neuropathy compared to what patients themselves report. A recent review identified over 20 different patient-reported outcome measures for CIPN alongside clinician scales and objective tests like nerve conduction studies, but noted that only a minority of these tools have been validated specifically in the chemo neuropathy population.²⁷

What this means in practice is that you should not wait for your oncologist to ask about leg pain or assume they will notice the severity from a brief exam. Keep a simple log of when the pain started, what makes it better or worse, where exactly you feel it, and how it affects your daily activities. Note whether it is triggered by cold, whether it is worse in both legs or just one, and whether it comes in waves after each infusion or stays constant. These details help your care team distinguish neuropathy from a taxane pain flare, a possible blood clot, or bone pain from a growth-factor injection, and each of those problems calls for a different response.